Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04950608

Organisation Name: Dana-Farber Cancer Institute

Overal Status: Recruiting

Start Date: March 9, 2022

Last Update: May 24, 2022

Lead Sponsor: Yvan Beaussant

Brief Summary: The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care.

-The name of the study drug involved in this study is Psilocybin

Conditions:
  • Hospice
  • Psilocybin
  • Demoralization
  • Terminal Illness
  • Cancer-related Problem/Condition
  • Psychotherapy
  • Terminal Cancer
  • Cancer Terminal


Total execution time in seconds: 0.61401104927063